Xtandi Capsules — Enzalutamide 40 mg (112 Caps) Astellas
Xtandi 40 mg (Enzalutamide) is an original, next-generation targeted anti-cancer medication. It is a potent androgen receptor inhibitor. The drug blocks the effects of testosterone on prostate cancer cells at three distinct steps, depriving the tumor of its primary growth stimulus and inducing cancer cell death.
Manufacturer: Astellas Pharma. 🇹🇷 Note: This product holds official Turkish registration. It is a 100% original medication manufactured by the developer (Astellas) and packaged for the Turkish domestic market. This ensures the highest standards of authentic quality while offering a more affordable price point compared to US and EU markets.
Key Features:
- ✅ High Efficacy: Clinically proven to extend overall survival and delay disease progression.
- ✅ Triple Mechanism: It doesn't just block androgen binding; it also prevents the receptors from entering the cell nucleus.
- ✅ Convenient Supply: A pack of 112 capsules provides exactly a 28-day (4-week) supply for the standard daily dose.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 09.04.2026
What Customers Say
No reviews yet
Your review can be the first!